Atem Capital Competitors or Alternatives

Atem Capital's top competitors include OrbiMed, Clinigence Holdings and Fannin.

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Atem Capital's company profile

Anton Gopka

CEO

85/100
1 - 25
$0
$5M - 25M
1
Atem Capital's Competitor - OrbiMed logo

Sven H. Borho

Managing Partner

88/100
130
$15.8B
$13.7M
2
Atem Capital's Competitor - Clinigence Holdings logo

John Salerno

CEO

90/100
1 - 25
$11.3M
$100K - 5M
3
Atem Capital's Competitor - Fannin logo

Atul Varadhachary

Managing Partner

86/100
24
$18M
$18.4M
4
Atem Capital's Competitor - Domain Associates, LLC logo

Debra Liebert

Managing Director

70/100
45
$163.6M
$8.2M
5
Atem Capital's Competitor - Aisling Capital logo

Andrew Schiff

Managing Partner

69/100
10
$423.1M
$15.1M

Atem Capital VS OrbiMed

OrbiMed is a top competitor of Atem Capital. OrbiMed is a Investment Company company that was founded in 1989 in New York, New York. OrbiMed operates in the Retail & Business Banking industry. Compared to Atem Capital, OrbiMed has 124 more employees.

Atem Capital VS Clinigence Holdings

Clinigence Holdings is seen as one of Atem Capital's biggest rivals. Clinigence Holdings was founded in 1996, and is headquartered in Houston, Texas. Clinigence Holdings is in the Diversified Investment Services industry. Clinigence Holdings generates $5.8M less revenue vs. Atem Capital.

Atem Capital VS Fannin

Fannin is seen as one of Atem Capital's top competitors. Fannin was founded in Houston, Texas} in 2005. Fannin competes in the Investment Banking and Securities industry. Compared to Atem Capital, Fannin generates $11.2M more revenue.

Frequently Asked Questions about Atem Capital

  1. Who are Atem Capital's top competitors?

    Atem Capital's top 3 competitors are OrbiMed, Clinigence Holdings, Fannin.
  2. Who is similar to Atem Capital?

    OrbiMed is the most similar to Atem Capital. Clinigence Holdings and Fannin are also similar to Atem Capital.
  1. Are Atem Capital and OrbiMed competitors?

    Yes, OrbiMed is one of Atem Capital’s top competitors.